Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T - Initial experience

Magnetic Resonance in Medicine

Volumn 58, Issue 6, 2007, Pages 1099-1106

  Chen, Albert P ^a   Albers, Mark J ^a   Cunningham, Charles H ^b,c   Kohler, Susan J ^d   Yen, Yi Fen ^d   Hurd, Ralph E ^d   Tropp, James ^d   Bok, Robert ^a   Pauly, John M ^e   Nelson, Sarah J ^a   Kurhanewicz, John ^a   Vigneron, Daniel B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d GE HEALTHCARE   (United States)

^e Stanford University   (United States)

Author keywords

C 13; DNP; Flyback; MRSI; TRAMP

Indexed keywords

BIOCHEMISTRY; DISEASES; SPIN POLARIZATION; TUMORS; UROLOGY;

DISEASE PROGRESSION; DYNAMIC NUCLEAR POLARIZATION; FLYBACK; HIGH SIGNALTO-NOISE RATIOS (SNR); MRSI; SPATIAL RESOLUTION; SPECTROSCOPIC IMAGING; TRAMP;

SIGNAL TO NOISE RATIO;

LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; HYPERPOLARIZATION; MALE; MEDICAL INSTRUMENTATION; METASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSTATE CANCER; PROSTATE EPITHELIUM; SIGNAL NOISE RATIO;

EID: 36849029752     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21256     Document Type: Article

References (24)

1. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995;92:3439-3443.
2. Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, Maddison LA, Foster BA, Greenberg NM. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 2003;55:219-237.
3. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002;16:451-463.
4. Coakley FV, Qayyum A, Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol 2003;170(6 Pt 2):S69-75; discussion S75-66.
5. Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll PR, Kurhanewicz J. Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magn Reson Med 2001;46:49-57.
6. Scheenen TW, Gambarota G, Weiland E, Klomp DW, Futterer JJ, Barentsz JO, Heerschap A. Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T. Magn Reson Med 2005;53:1268-1274.
7. Fricke ST, Rodriguez O, VanMeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C. In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer model. Prostate 2006;66:708-717.
8. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci USA 2003;100:10158-10163.
9. Golman K, Ardenkjaer-Larsen JH, Peterson JS, Mansson S, Leunbach I. Molecular Imaging with endogenous substances. Proc Natl Acad Sci USA 2003;100:10435-10439.
10. Kohler SJ, Yen Y, Wolber J, Zandt R, Gram A, Ellner F, Thaning M, Chen AP, Albers M, Bok RA, Tropp J, Nelson SJ, Vigneron DB, Kurhanewicz J, Hurd R. Carbon-13 metabolic imaging at 3T using hyperpolarized 13C-1-pyruvate. In: Proceedings of the 14th Annual Meeting of ISMRM, Seattle, WA, USA, 2006 (Abstract 586).
11. Golman K, Zandt R, Thaning M. Real-time metabolic imaging. Proc Natl Acad Sci USA 2006;103:11270-11275.
12. 129Xe MR. J Magn Reson B 1996;113:179-183.
13. Cunningham C, Vigneron D, Chen A, Xu D, Nelson S, Hurd R, Kelley D, Pauly J. Design of flyback echo-planar readout gradients for magnetic resonance spectroscopic imaging. Magn Reson Med 2005;54:1286-1289.
14. Derby K, Tropp J, Hawryszko C. Design and evaluation of a novel dual-tuned resonator for spectroscopic imaging. J Magn Reson 1990;86:645-651.
15. Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001;153:155-177.
16. Conolly S, Glover G, Nishimura D, Macovski A. A reduced power selective adiabatic spin-echo pulse sequence. Magn Reson Med 1991;18:28-38.
17. Posse S, Tedeschi G, Risinger R, Ogg R, Le BD. High speed 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Reson Med 1995;33:34-40.
18. Dreher W, Leibfritz D. Fast proton spectroscopic imaging with high signal-to-noise ratio: spectroscopic RARE. Magn Reson Med 2002;47:523-528.
19. Nelson S. Analysis of volume MRI and MR Spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 2003;46:228-239.
20. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 1998;35:285-296.
21. Costello LC, Franklin RB. Bioenergetic theory of prostate malignancy. Prostate 1994;25:162-166.
22. Cornel EB, Smits GA, Oosterhof GO, Karthaus HF, Deburyne FM, Schalken JA, Heerschap A. Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy. J Urol 1993;150:2019-2024.
23. 13C MR angiography using True FISP. Magn Reson Med 2003;50:256-262.
24. Dreher W, Leibfritz D. A new method for fast proton spectroscopic imaging: spectroscopic GRASE. Magn Reson Med 2000;44:668-672.